Economic burden of multiple sclerosis in france estimated from a regional medical registry and national sick fund claims

ConclusionsCosts were mainly driven by medications and highly related to disease severity. Relapse cost was the main contributor to total cost.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research